Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT05233215

GROW (Glioma Specialists Reaching Out With Support) Support

GROW Support (Glioma Specialists Reaching Out With Support): Assessment of a Comprehensive Support Program for Low Grade Glioma Patients Post-treatment

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Dana-Farber Cancer Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This research study is being done to test a participant and caregiver-driven model of follow-up survivorship care,GROW Support (Glioma Specialists Reaching Out With Support), for post-treatment, low grade glioma patients.

Detailed description

This research study is a Feasibility Study, which examines if a supportive intervention for people with low grade gliomas (LGGs) and their caregivers is acceptable and feasible to patients and their caregivers. The research study procedures include: screening for eligibility and study interventions including filling out questionnaires and virtual or in-clinic supportive follow up visits to identify additional supportive needs that may arise. Participants will be in this research study for up to 6 months. It is expected that about 40 people will take part in this research study. The Levitan-Zabin Fund for GROW Support is supporting this research study by providing funds for research team members to do this study.

Conditions

Interventions

TypeNameDescription
BEHAVIORALGROW (Glioma Specialists Reaching Out With Support) Support ProgramFollow-up survivorship care plan for patients and caregivers

Timeline

Start date
2022-07-01
Primary completion
2023-12-15
Completion
2024-06-15
First posted
2022-02-10
Last updated
2023-01-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05233215. Inclusion in this directory is not an endorsement.